Number of the records: 1
heparín
SYS d006493 LBL 00000cz--a2200000n--4500 005 20250619142535.9 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D09.698.373.400 066 $a 01 $c 03 150 $a heparín $x AA $x AD $x AE $x AG $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $2 slo 450 $w v $a alpha-Heparin $2 eng 450 $w v $a Heparinic Acid $2 eng 450 $w v $a kyselina heparínová $2 slo 450 $w v $a alfa-heparín $2 slo 450 $w v $a Liquaemin $2 slo 450 $w v $a heparín nefrakcionovaný $2 slo 450 $w v $a heparín sodný $2 slo 550 $7 sllk_us_auth*d000925 $Y Anticoagulants $w P $a antikoagulanciá 550 $7 sllk_us_auth*d005343 $Y Fibrinolytic Agents $w P $a fibrinolytiká 665 $a /therapeutic use was HEPARIN, THERAPEUTIC 1965 $2 eng 680 9-
$i A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. $2 eng 750 -2
$a Heparin $2 eng 980 $x M
Number of the records: 1